$AGYS Cashflow Statement | Understand Stock

$AGYS

$123.45 +$2.76 (2.29%) Close

$AGYS Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2026 12 months to Mar 31, 2026	FY2025 12 months to Mar 31, 2025	FY2024 12 months to Mar 31, 2024	FY2023 12 months to Mar 31, 2023	FY2022 12 months to Mar 31, 2022
Operating activities
Net income
Adjustments to reconcile net income to net cash provided by operating activities:
Impairments
Loss (gain) on asset disposals
Depreciation of fixed assets
Amortization of internal-use software and intangibles
Amortization of developed technology
Amortization of developed technology acquired
Deferred income taxes
Share-based compensation

Changes in operating assets and liabilities:
Accounts receivable
Contract assets
Inventory
Prepaids and other current assets
Accounts payable
Contract liabilities
Accrued liabilities
Income taxes payable, net
Other changes, net
Net cash provided by operating activities
Investing activities
Cash paid for business combination, net of cash acquired
Capital expenditures
Proceeds from sale of assets
Additional investments in corporate-owned life insurance policies
Net cash used in investing activities
Financing activities
Preferred stock issuance proceeds, net of issuance costs
Payment of preferred stock dividends
Debt proceeds, net of issuance costs
Debt repayments
Proceeds from Employee Stock Purchase Plan purchases
Repurchase of common shares to satisfy employee tax withholding
Principal payments under long-term obligations
Net cash provided by (used in) financing activities

Effect of exchange rate changes on cash
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period

Comments